暗盤收盤 | 聖諾醫藥-B、泉峯控股、商湯-W輝立暗盤漲0.08%、漲15.25%、跌0.52%,富途暗盤跌1.14%、漲17.32%、跌1.04%
12月29日,聖諾醫藥-B(02257)輝立暗盤上漲0.08%,報於65.95港元,成交額924萬港元;富途暗盤下跌1.14%,報於65.15港元,成交額89.6萬港元。發行價爲65.9港元。
公司簡介:Sirnaomics Ltd.是在中國及美國均佔有重要市場地位的首家及唯一一家臨牀階段RNA療法生物製藥公司,正探索及開發創新藥物,用於具有顯着未滿足醫療需求及龐大市場機會的適應症。我們是首家在腫瘤學RNAi治療領域取得積極IIa期臨牀結果的公司。
泉峯控股(02285)輝立暗盤上漲15.25%,報於50.25港元,成交額5720萬港元;富途暗盤上漲17.32%,報於51.15港元,成交額2283.54萬港元。發行價爲43.6港元。
公司簡介:我們爲中國第一大電動工具及戶外動力設備(「OPE」)全球供應商。
商湯-W(00020)輝立暗盤下跌0.52%,報於3.83港元,成交額2670萬港元;富途暗盤下跌1.04%,報於3.81港元,成交額3572.87萬港元。發行價爲3.85港元。
公司簡介:作爲人工智能軟件公司,商湯科技以“堅持原創,讓AI引領人類進步”爲使命,“以人工智能實現物理世界和數字世界的連接,促進社會生產力可持續發展,併爲人們帶來更好的虛實結合生活體驗”爲願景,旨在持續引領人工智能前沿研究,持續打造更具拓展性更普惠的人工智能軟件平臺,推動經濟、社會和人類的發展,並持續吸引及培養頂尖人才,共同塑造未來。
uSMART智能寫手的信息、數據均來自媒體公開報道,智能寫手不能保證其完全準確,內容僅供參考,不構成投資建議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.